Cargando…
OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019471/ https://www.ncbi.nlm.nih.gov/pubmed/27660487 http://dx.doi.org/10.2147/JPR.S117219 |
| _version_ | 1782453065821978624 |
|---|---|
| author | Fudin, Jeffrey Raouf, Mena Wegrzyn, Erica L |
| author_facet | Fudin, Jeffrey Raouf, Mena Wegrzyn, Erica L |
| author_sort | Fudin, Jeffrey |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5019471 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50194712016-09-22 OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form Fudin, Jeffrey Raouf, Mena Wegrzyn, Erica L J Pain Res Editorial Dove Medical Press 2016-09-07 /pmc/articles/PMC5019471/ /pubmed/27660487 http://dx.doi.org/10.2147/JPR.S117219 Text en © 2016 Fudin et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
| spellingShingle | Editorial Fudin, Jeffrey Raouf, Mena Wegrzyn, Erica L OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form |
| title | OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form |
| title_full | OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form |
| title_fullStr | OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form |
| title_full_unstemmed | OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form |
| title_short | OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form |
| title_sort | oxycontin was submitted and justifiably approved by the agency as a 12-hour dosage form |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019471/ https://www.ncbi.nlm.nih.gov/pubmed/27660487 http://dx.doi.org/10.2147/JPR.S117219 |
| work_keys_str_mv | AT fudinjeffrey oxycontinwassubmittedandjustifiablyapprovedbytheagencyasa12hourdosageform AT raoufmena oxycontinwassubmittedandjustifiablyapprovedbytheagencyasa12hourdosageform AT wegrzynerical oxycontinwassubmittedandjustifiablyapprovedbytheagencyasa12hourdosageform |